IZOVAC H120-B1 HITCHNER
IZOVAC H120-B1 HITCHNER
Authorised
- Newcastle disease virus, strain B1 Hitchner, Live
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
- Casein hydrolysate
Product identification
Medicine name:
IZOVAC H120-B1 HITCHNER
Active substance:
- Newcastle disease virus, strain B1 Hitchner, Live
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
- Casein hydrolysate
Target species:
-
Chicken
Route of administration:
-
In drinking water/milk use
Product details
Active substance and strength:
-
Newcastle disease virus, strain B1 Hitchner, Live6.00/log 10 50% embryo infective dose1.00Dose
-
Avian infectious bronchitis virus, type Massachusetts, strain H120, Live3.00/log 10 50% embryo infective dose1.00Dose
-
Casein hydrolysate18.00/microgram(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
In drinking water/milk use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Izo S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
- Izo S.r.l.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 10/09/2025